Granahan Investment Management - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,353,732
-40.8%
851,201
+59.7%
0.12%
-31.6%
Q2 2023$5,664,514
+12.7%
532,880
-11.7%
0.17%
+13.7%
Q1 2023$5,027,355
-1.0%
603,524
+9.7%
0.15%
-1.3%
Q4 2022$5,078,521
+52.7%
550,219
+112.4%
0.16%
+42.2%
Q3 2022$3,326,000
+26.8%
259,014
+30.4%
0.11%
+21.1%
Q2 2022$2,624,000198,6210.09%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Skorpios Trust 14,443,681$56,908,10399.78%
Lynx1 Capital Management LP 1,710,154$6,738,0074.46%
COWEN AND COMPANY, LLC 3,721,659$14,663,3361.03%
Redmile Group, LLC 3,872,696$15,258,4220.73%
RTW INVESTMENTS, LP 4,390,558$17,298,7990.36%
Birchview Capital, LP 85,000$334,9000.28%
Cormorant Asset Management, LP 1,087,807$4,285,9600.25%
Granahan Investment Management 851,201$3,353,7320.12%
GSA CAPITAL PARTNERS LLP 348,069$1,3710.12%
Simplify Asset Management Inc. 102,985$405,7610.05%
View complete list of STOKE THERAPEUTICS INC shareholders